135 related articles for article (PubMed ID: 35372654)
41. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Kim S; Lee M; Shin HJ; Lee J; Suh YL
Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
[TBL] [Abstract][Full Text] [Related]
42. Langerhans Cell Histiocytosis with Uncommon Liver Involvement: A Case Report.
Reginelli A; Pignatiello M; Urraro F; Belfiore MP; Toni G; Vacca G; Cappabianca S
Am J Case Rep; 2020 Nov; 21():e923505. PubMed ID: 33190140
[TBL] [Abstract][Full Text] [Related]
43. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
Berres ML; Merad M; Allen CE
Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
[TBL] [Abstract][Full Text] [Related]
44. Spontaneous Thyroid Hemorrhage Caused by Langerhans Cell Histiocytosis: A Case Report and Literature Review.
Zhang J; Wang C; Lin C; Bai B; Ye M; Xiang D; Li Z
Front Endocrinol (Lausanne); 2021; 12():610573. PubMed ID: 34093427
[TBL] [Abstract][Full Text] [Related]
45. Langerhans cell histiocytosis of the female genital tract: a literature review.
Montero AJ; Díaz-Montero CM; Malpica A; Ramirez PT; Kavanagh JJ
Int J Gynecol Cancer; 2003; 13(3):381-8. PubMed ID: 12801274
[TBL] [Abstract][Full Text] [Related]
46. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary thyroid langerhans histiocytosis: A case report and literature review.
Long Q; Shaoyan W; Hui W
Indian J Nucl Med; 2015; 30(4):328-30. PubMed ID: 26430317
[TBL] [Abstract][Full Text] [Related]
47. FDG PET-CT in pediatric Langerhans cell histiocytosis.
Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
[TBL] [Abstract][Full Text] [Related]
48. A Case with Juvenile Xanthogranuloma and Progressive Nodular Histiocytosis Overlap.
Guidolin L; Noguera-Morel L; Hernández-Martín A; Fernández-Llaca H; Rodríguez-Peralto JL; Torrelo A
Pediatr Dermatol; 2017 Mar; 34(2):e102-e103. PubMed ID: 28297144
[TBL] [Abstract][Full Text] [Related]
49. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
[TBL] [Abstract][Full Text] [Related]
50. A rare case of coexistence of pulmonary adenocarcinoma with Langerhans' cell histiocytosis.
Ohtsuki Y; Uomoto M; Hachisuka Y; Kato M; Iguchi M; Lee GH; Furihata M
Med Mol Morphol; 2008 Sep; 41(3):175-8. PubMed ID: 18807145
[TBL] [Abstract][Full Text] [Related]
51. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
52. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children.
Zeng K; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Z; Guo S; Yan Q; Guo Y
Hematol Oncol; 2017 Dec; 35(4):845-851. PubMed ID: 27597420
[TBL] [Abstract][Full Text] [Related]
53. Recent advances in Langerhans cell histiocytosis.
Morimoto A; Oh Y; Shioda Y; Kudo K; Imamura T
Pediatr Int; 2014 Aug; 56(4):451-61. PubMed ID: 24840547
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: a case report.
Hesseling PB; Wessels G; Egeler RM; Rossouw DJ
Pediatr Hematol Oncol; 1995; 12(2):135-41. PubMed ID: 7626381
[TBL] [Abstract][Full Text] [Related]
55. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
[TBL] [Abstract][Full Text] [Related]
56. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
Hage C; Willman CL; Favara BE; Isaacson PG
Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
[TBL] [Abstract][Full Text] [Related]
57. Localized Acral Sclerosing Langerhans Cell Histiocytosis: A New Form of Presentation of Cutaneous Langerhans Cell Histiocytosis.
Garrido MC; Salido-Vallejo R; Revilla E; Salvatierra J; Rodriguez-Peralto JL
Am J Dermatopathol; 2020 May; 42(5):356-359. PubMed ID: 31725482
[TBL] [Abstract][Full Text] [Related]
58. Cyclin D1: potential utility as marker for Langerhans cell histiocytosis.
Ben Rejeb S; Charfi L; Sahraoui G; Boujelben N; Mrad K; Doghri R
J Immunoassay Immunochem; 2021 Jul; 42(4):370-379. PubMed ID: 33444078
[TBL] [Abstract][Full Text] [Related]
59. Cholesteatoma as a complication of Langerhans Cell Histiocytosis of the temporal bone: A nationwide cross-sectional analysis.
Simmonds JC; Vecchiotti M
Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():66-70. PubMed ID: 28802389
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.
Sholl LM; Hornick JL; Pinkus JL; Pinkus GS; Padera RF
Am J Surg Pathol; 2007 Jun; 31(6):947-52. PubMed ID: 17527085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
